MedTrace Logo

Study to Evaluate Satisfaction After Treatment With Restylane

NCT04638816 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-06

Study results available
· View outcomes & findings →

Summary

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Restylane

Conditions

  • Cheek Augmentation

Interventions

DEVICE

Restylane Volyme

Hyaluronic Acid: Injectable gel for contouring effect (of cheek volumization).

DEVICE

Restylane Lyft Lidocaine

Hyaluronic Acid: Injectable gel for projection effect (of cheek augmentation).

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Study Director · Galderma R&D

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-16
Primary Completion
2021-07-03
Completion
2021-08-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638816 on ClinicalTrials.gov